Stiglund et al. [52] demonstrated the potential of ST1A1, ADA, Flt3L, EN-RAGE, IL-6, and IL-18 as biomarkers for MASH. The gene discussed is ADA; the disease is metabolic dysfunction-associated steatohepatitis.